Generalized Anxiety
26
6
7
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 26 trials
100.0%
+13.5% vs benchmark
19%
5 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (26)
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
Optimization of Late Imagery Rescripting Research Using Generative Artificial Intelligence
Enhancing Health in Rural Populations: Music as Therapy
Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.
Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression
Project Collabri for Treatment of Anxiety
Common Factors Group Psychotherapy for General Mental Health Concerns
Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence
Experiences of Anger in Patients in Primary Health Care With Symptoms of Generalized Anxiety
Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19
CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT
Cerina-A Pilot Randomized Controlled Trial
Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms
Scaling Mental Healthcare in COVID-19 With Voice Biomarkers
Improving Access to Child Anxiety Treatment
Brain Stimulation & Generalized Anxiety Study
The Impact of Information Sources on Mental Health During the COVID-19 Pandemic
Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic